Document
IPR2018-00125, No. 2014 Exhibit - Larryn W Peterson Charles E McKenna, Prodrug Approaches to Improving the Oral Absorption of Antiviral Nucleotide Analogues, 6 EXPERT OPINION ON DR...
Cite Document
IPR2018-00125, No. 2014 Exhibit - Larryn W Peterson Charles E McKenna, Prodrug Approaches to Improving the Oral Absorption of Antiviral Nucleotide Analogues, 6 EXPERT OPINION ON DRUG DELIVERY 405 420
+ More Snippets
Document
IPR2018-00125, No. 2001 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices, I MAK 2017 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2001 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices, I MAK 2017 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2010 Exhibit - Donald Voet et al, FUNDAMENTALS OF BIOCHEMISTRY 3d ed 2008 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2010 Exhibit - Donald Voet et al, FUNDAMENTALS OF BIOCHEMISTRY 3d ed 2008 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2004 Exhibit - Michael J Sofia et al, Discovery of a ¿¿ d 2 Deoxy 2¿¿¿ ¿¿ fluoro 2 ¿¿ C methyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus, 53 JOURN...
Cite Document
IPR2018-00125, No. 2004 Exhibit - Michael J Sofia et al, Discovery of a ¿¿ d 2 Deoxy 2¿¿¿ ¿¿ fluoro 2 ¿¿ C methyluridine Nucleotide Prodrug PSI 7977 for the Treatment of Hepatitis C Virus, 53 JOURNAL
+ More Snippets
Document
IPR2018-00125, No. 2011 Exhibit - Lars P Jordheim et al, Advances in the Development of Nucleoside and Nucleotide Analogues for Cancer and Viral Diseases, 12 NATURE REVIEWS 447 464 2...
Cite Document
IPR2018-00125, No. 2011 Exhibit - Lars P Jordheim et al, Advances in the Development of Nucleoside and Nucleotide Analogues for Cancer and Viral Diseases, 12 NATURE REVIEWS 447 464 2013 (P.T.A.B. Mar.
+ More Snippets
Document
IPR2018-00125, No. 2007 Exhibit - Andrew Pollack, FDA Approves Pill to Treat Hepatitis C, THE NEW YORK TIMES, 2013 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2007 Exhibit - Andrew Pollack, FDA Approves Pill to Treat Hepatitis C, THE NEW YORK TIMES, 2013 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2006 Exhibit - Miriam E Tucker, FDA Approves Game Changer Hepatitis C Drug Sofosbuvir, MEDSCAPE, 2013 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2006 Exhibit - Miriam E Tucker, FDA Approves Game Changer Hepatitis C Drug Sofosbuvir, MEDSCAPE, 2013 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2008 Exhibit - Jonathan D Rockoff, FDA Approves Gilead¿¿¿s Hepatitis C Drug THE WALL STREET JOURNAL, 2013 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2008 Exhibit - Jonathan D Rockoff, FDA Approves Gilead¿¿¿s Hepatitis C Drug THE WALL STREET JOURNAL, 2013 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2002 Exhibit - Our People, I MAK 2018 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2002 Exhibit - Our People, I MAK 2018 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2003 Exhibit - S Zeuzem et al, Expert Opinion on the Treatment of Patients with Chronic Hepatitis C, 16 JOURNAL OF VIRAL HEPATITIS 75 90 2009 (P.T.A.B. Mar. 19, 2018...
Cite Document
IPR2018-00125, No. 2003 Exhibit - S Zeuzem et al, Expert Opinion on the Treatment of Patients with Chronic Hepatitis C, 16 JOURNAL OF VIRAL HEPATITIS 75 90 2009 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2013 Exhibit - OXFORD DICTIONARY OF BIOCHEMISTRY AND MOLECULAR BIOLOGY rev ed 2000 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2013 Exhibit - OXFORD DICTIONARY OF BIOCHEMISTRY AND MOLECULAR BIOLOGY rev ed 2000 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2009 Exhibit - Eric Lawitz et al Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection, 1358 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 56 6...
Cite Document
IPR2018-00125, No. 2009 Exhibit - Eric Lawitz et al Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection, 1358 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 56 67 2014 (P.T.A.B. Mar
+ More Snippets
Document
IPR2018-00125, No. 2012 Exhibit - IUPAC, COMPENDIUM OF CHEMICAL TERMINOLOGY GOLD BOOK 2014 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2012 Exhibit - IUPAC, COMPENDIUM OF CHEMICAL TERMINOLOGY GOLD BOOK 2014 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
IPR2018-00125, No. 2005 Exhibit - Michael J Sofia, Nucleotide Prodrugs for HCV Therapy, 22 ANTIVIRAL CHEMISTRY and CHEMOTHERAPY 23 49 2011 (P.T.A.B. Mar. 19, 2018)
Cite Document
IPR2018-00125, No. 2005 Exhibit - Michael J Sofia, Nucleotide Prodrugs for HCV Therapy, 22 ANTIVIRAL CHEMISTRY and CHEMOTHERAPY 23 49 2011 (P.T.A.B. Mar. 19, 2018)
+ More Snippets
Document
EPCLUSA, 208341, Letter (Orange Book Jun. 10, 2021)
Cite Document
EPCLUSA, 208341, Letter (Orange Book Jun. 10, 2021)
+ More Snippets